Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1687932/000095014219000480/eh1900359_8k.htm
March 2023
December 2022
September 2022
June 2022
June 2022
April 2022
March 2022
January 2022
December 2021
September 2021
·
|
Total net sales for the thirteen weeks ended February 2, 2019 were $170.9 million versus $188.7 million for the fourteen weeks ended February 3, 2018.
|
·
|
Total company comparable sales, which includes comparable store and direct to consumer sales, decreased by 1.7%.
|
·
|
Direct to consumer net sales represented 45.3% of total net sales, compared to 46.6% in the fourth quarter of fiscal 2017.
|
·
|
Gross profit decreased to $107.8 million from $117.3 million in the fourth quarter of fiscal 2017. Gross margin was 63.1% compared to fourth quarter gross margin of 62.2% in fiscal 2017.
|
·
|
SG&A was $99.8 million compared to $105.6 million in the fourth quarter of fiscal 2017. Fourth quarter 2017 SG&A included $2.3 million of non-recurring expenses. Excluding these non-recurring expenses, SG&A as a percentage of total net sales was 58.4% compared to 54.8% in the fourth quarter of fiscal 2017.
|
·
|
Income from operations decreased to $8.0 million from $11.7 million in the fourth quarter of fiscal 2017, which is inclusive of non-recurring SG&A expenses.
|
·
|
Interest expense remained flat at $4.7 million for both the fourth quarter of fiscal 2018 and the fourth quarter of fiscal 2017.
|
·
|
Income tax expense was $1.2 million compared to an income tax benefit of $22.4 million in the fourth quarter of fiscal 2017, and the effective tax rate was 37.1% compared to (320.3%) in the fourth quarter of 2017. The U.S. Tax Cuts and Jobs Act, enacted in December 2017, significantly reduced the federal corporate income tax rate, and required the Company to revalue its deferred income tax liabilities based on the lower enacted federal corporate income tax rate, resulting in a one-time benefit of $24.0 million in the fourth quarter of fiscal 2017.
|
·
|
Net income decreased to $2.1 million from $29.3 million in the fourth quarter of fiscal 2017, which is inclusive of non-recurring SG&A expenses.
|
·
|
Diluted earnings per share was $0.05 compared to $0.67 in the fourth quarter of fiscal 2017, which included the impact of one-time expenses and tax reform. Excluding these impacts, Adjusted Diluted Earnings per Share* for the fourth quarter of fiscal 2017 was $0.13.
|
·
|
Adjusted EBITDA* for the fourth quarter of fiscal 2018 decreased by 23.6% to $18.5 million from $24.2 million in the fourth quarter of fiscal 2017. As a percentage of total net sales, Adjusted EBITDA was 10.8% compared to 12.8% in the fourth quarter of fiscal 2017.
|
·
|
Total net sales for the fifty-two weeks ended February 2, 2019 were $706.3 million versus $698.1 million for the fifty-three weeks ended February 3, 2018.
|
·
|
Total company comparable sales, which includes comparable store and direct to consumer sales, increased by 0.9%.
|
·
|
Direct to consumer net sales represented 41.6% of total net sales compared to 43.1% in fiscal 2017.
|
·
|
Gross profit decreased to $460.3 million from $464.1 million in fiscal 2017. Gross margin was 65.2% compared to 66.5% in fiscal 2017.
|
·
|
SG&A was $399.0 million compared to $394.9 million in fiscal 2017. In fiscal 2018, SG&A included $1.3 million of non-recurring expenses and $0.2 million of accelerated stock compensation expense as a result of a CEO transition. In fiscal 2017, SG&A included $7.2 million of non-recurring expenses related to the Company’s IPO and subsequent transition to a public company. Excluding these non-recurring expenses in both years, SG&A as a percentage of total net sales was 56.3% compared to 55.5% in fiscal 2017.
|
·
|
Income from operations, inclusive of non-recurring SG&A expenses, decreased to $61.2 million from $69.2 million in fiscal 2017.
|
·
|
Interest expense was $19.1 million compared to $19.3 million, including accelerated deferred financing amortization of $0.7 million due to the voluntary paydown of $25.0 million of the Company’s Term Loan in fiscal 2017.
|
·
|
Income tax expense was $11.6 million compared to an income tax benefit of $5.4 million in fiscal 2017, and the effective tax rate was 27.6% compared to (10.9%) in fiscal 2017. The U.S. Tax Cuts and Jobs Act, enacted in December 2017, significantly reduced the federal corporate income tax rate, and required the Company to revalue its deferred income tax liabilities based on the lower enacted federal corporate income tax rate, resulting in a one-time benefit of $24.0 million in the fourth quarter of fiscal 2017.
|
·
|
Net income, inclusive of non-recurring SG&A expenses, decreased to $30.5 million from $55.4 million in fiscal 2017.
|
·
|
Diluted earnings per share was $0.69 compared to $1.27 in fiscal 2017, including the impact of one-time expenses and tax reform. Excluding these impacts, Adjusted Diluted Earnings per Share* in fiscal 2017 was $0.79.
|
·
|
Adjusted EBITDA* in fiscal 2018 decreased by 8.8% to $103.5 million from $113.5 million in fiscal 2017. As a percentage of total net sales, Adjusted EBITDA was 14.7% compared to 16.3% in fiscal 2017.
|
·
|
Adjusted EBITDA, which represents net income (loss) plus interest expense, provision (benefit) for income taxes, depreciation and amortization, equity-based compensation expense, write-off of property and equipment, and other non-recurring expenses and one-time items. We present Adjusted EBITDA on a consolidated basis because management uses it as a supplemental measure in assessing our operating performance, and we believe that it is helpful to investors, securities analysts and other interested parties as a measure of our comparative operating performance from period to period. We also use Adjusted EBITDA as one of the primary methods for planning and forecasting overall expected performance of our business and for evaluating on a quarterly and annual basis actual results against such expectations. Further, we recognize Adjusted EBITDA as a commonly used measure in determining business value and as such, use it internally to report results.
|
·
|
Adjusted Net Income, which represents net income (loss) plus other non-recurring expenses and one-time items. We present Adjusted Net Income on a consolidated basis because management uses it as a supplemental measure in assessing our operating performance, and we believe that it is helpful to investors, securities analysts and other interested parties as a measure of our comparative operating performance from period to period.
|
·
|
Adjusted Diluted Earnings per Share (“Adjusted Diluted EPS”) represents Adjusted Net Income divided by the number of fully diluted shares outstanding. Adjusted Diluted EPS is presented as a supplemental measure in assessing our operating performance, and we believe that it is helpful to investors, securities analysts and other interested parties as a measure of our comparative operating performance from period to period.
|
For the Thirteen Weeks Ended
|
For the Fourteen Weeks Ended
|
|||||||
February 2, 2019
|
February 3, 2018
|
|||||||
Net sales
|
$
|
170,902
|
$
|
188,672
|
||||
Cost of goods sold
|
63,081
|
71,344
|
||||||
Gross profit
|
107,821
|
117,328
|
||||||
Selling, general and administrative expenses
|
99,794
|
105,609
|
||||||
Operating income
|
8,027
|
11,719
|
||||||
Interest expense, net
|
4,696
|
4,736
|
||||||
Income before provision for income taxes
|
3,331
|
6,983
|
||||||
Income tax provision (benefit)
|
1,237
|
(22,365
|
)
|
|||||
Net income and total comprehensive income
|
$
|
2,094
|
$
|
29,348
|
||||
Net income per common share attributable to common shareholders
|
||||||||
Basic
|
$
|
0.05
|
$
|
0.70
|
||||
Diluted
|
$
|
0.05
|
$
|
0.67
|
||||
Weighted average number of common shares outstanding
|
||||||||
Basic
|
43,060,392
|
41,906,414
|
||||||
Diluted
|
44,359,599
|
43,499,744
|
For the Fifty-Two Weeks Ended
|
For the Fifty-Three Weeks Ended
|
|||||||
February 2, 2019
|
February 3, 2018
|
|||||||
Net sales
|
$
|
706,262
|
$
|
698,145
|
||||
Cost of goods sold
|
245,982
|
234,065
|
||||||
Gross profit
|
460,280
|
464,080
|
||||||
Selling, general and administrative expenses
|
399,042
|
394,893
|
||||||
Operating income
|
61,238
|
69,187
|
||||||
Interest expense, net
|
19,064
|
19,261
|
||||||
Income before provision for income taxes
|
42,174
|
49,926
|
||||||
Income tax provision (benefit)
|
11,649
|
(5,439
|
)
|
|||||
Net income and total comprehensive income
|
$
|
30,525
|
$
|
55,365
|
||||
Net income per common share attributable to common shareholders
|
||||||||
Basic
|
$
|
0.71
|
$
|
1.32
|
||||
Diluted
|
$
|
0.69
|
$
|
1.27
|
||||
Weighted average number of common shares outstanding
|
||||||||
Basic
|
42,771,316
|
41,926,157
|
||||||
Diluted
|
44,239,751
|
43,571,746
|
February 2, 2019
|
February 3, 2018
|
|||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash
|
$
|
66,204
|
$
|
25,978
|
||||
Accounts receivable
|
4,007
|
4,733
|
||||||
Inventories, net
|
77,349
|
80,591
|
||||||
Prepaid expenses and other current assets
|
27,734
|
21,166
|
||||||
Total current assets
|
175,294
|
132,468
|
||||||
Property and equipment, net
|
118,044
|
118,420
|
||||||
Intangible assets, net
|
136,177
|
148,961
|
||||||
Goodwill
|
197,026
|
197,026
|
||||||
Other assets
|
447
|
682
|
||||||
Total assets
|
$
|
626,988
|
$
|
597,557
|
||||
Liabilities and Shareholders’ Equity
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
55,012
|
$
|
53,962
|
||||
Accrued expenses and other current liabilities
|
45,306
|
48,759
|
||||||
Current portion of long-term debt
|
2,799
|
2,799
|
||||||
Total current liabilities
|
103,117
|
105,520
|
||||||
Long-term debt, net of discount and current portion
|
237,464
|
238,881
|
||||||
Deferred income taxes
|
41,842
|
46,263
|
||||||
Other liabilities
|
30,770
|
27,577
|
||||||
Total liabilities
|
413,193
|
418,241
|
||||||
Shareholders’ Equity
|
||||||||
Common stock, par value $0.01 per share; 250,000,000 shares authorized;
43,672,418 and 43,752,790 shares issued and outstanding at February 2, 2019 and February 3, 2018, respectively
|
437
|
437
|
||||||
Additional paid-in capital
|
121,635
|
117,393
|
||||||
Accumulated earnings
|
91,723
|
61,486
|
||||||
Total shareholders’ equity
|
213,795
|
179,316
|
||||||
Total liabilities and shareholders’ equity
|
$
|
626,988
|
$
|
597,557
|
For the Thirteen Weeks Ended
|
For the Fourteen Weeks Ended
|
|||||||
February 2, 2019
|
February 3, 2018
|
|||||||
Net income
|
$
|
2,094
|
$
|
29,348
|
||||
Interest expense, net
|
4,696
|
4,736
|
||||||
Income tax provision (benefit)
|
1,237
|
(22,365
|
)
|
|||||
Depreciation and amortization
|
9,351
|
9,284
|
||||||
Equity-based compensation expense (a)
|
1,056
|
243
|
||||||
Write-off of property and equipment (b)
|
41
|
17
|
||||||
Impairment of long lived assets (c)
|
—
|
2,164
|
||||||
Special bonus
|
—
|
624
|
||||||
Other non-recurring expenses (d)
|
—
|
117
|
||||||
Adjusted EBITDA
|
$
|
18,475
|
$
|
24,168
|
||||
For the Fifty-Two Weeks Ended
|
For the Fifty-Three Weeks Ended
|
|||||||
February 2, 2019
|
February 3, 2018
|
|||||||
Net income
|
$
|
30,525
|
$
|
55,365
|
||||
Interest expense, net
|
19,064
|
19,261
|
||||||
Income tax provision (benefit)
|
11,649
|
(5,439
|
)
|
|||||
Depreciation and amortization
|
36,749
|
35,052
|
||||||
Equity-based compensation expense (a)
|
4,010
|
782
|
||||||
Write-off of property and equipment (b)
|
128
|
586
|
||||||
Impairment of long lived assets (c)
|
—
|
2,164
|
||||||
Special bonus
|
—
|
624
|
||||||
Other non-recurring expenses (d)
|
1,346
|
5,081
|
||||||
Adjusted EBITDA
|
$
|
103,471
|
$
|
113,476
|
(a): |
Represents expenses associated with equity incentive instruments granted to our management and board of directors. Incentive instruments are accounted for as equity-classified awards with the related compensation expense recognized based on fair value at the date of the grants.
|
(b): |
Represents net gain or loss on the disposal of fixed assets.
|
(c): |
Represents the impairment of assets taken in fiscal 2017 associated with three underperforming retail locations.
|
(d): |
Represents items management believes are not indicative of ongoing operating performance. These expenses are primarily composed of legal and professional fees associated with the initial public offering completed March 14, 2017 and subsequent transition to a public company. For the fifty-two weeks ended February 2, 2019, these expenses include costs related to a CEO transition.
|
For the Thirteen Weeks Ended
|
For the Fourteen Weeks Ended
|
|||||||
February 2, 2019
|
February 3, 2018
|
|||||||
Net income and total comprehensive income
|
$
|
2,094
|
$
|
29,348
|
||||
Add: Income tax provision (benefit)
|
1,237
|
(22,365
|
)
|
|||||
Income before income tax provision (benefit)
|
3,331
|
6,983
|
||||||
Add: Impairment of long lived assets (a)
|
—
|
2,164
|
||||||
Add: Other non-recurring expenses(b)
|
—
|
117
|
||||||
Adjusted Income before provision for income taxes
|
3,331
|
9,264
|
||||||
Less: Adjusted Tax Provision (c)(d)
|
1,237
|
3,706
|
||||||
Adjusted net income
|
$
|
2,094
|
$
|
5,558
|
||||
Adjusted net income per common share attributable to common shareholders
|
||||||||
Basic
|
$
|
0.05
|
$
|
0.13
|
||||
Diluted
|
$
|
0.05
|
$
|
0.13
|
||||
Weighted average number of common shares outstanding
|
||||||||
Basic
|
43,060,392
|
41,906,414
|
||||||
Diluted
|
44,359,599
|
43,499,744
|
For the Fifty-Two Weeks Ended
|
For the Fifty-Three Weeks Ended
|
|||||||
February 2, 2019
|
February 3, 2018
|
|||||||
Net income and total comprehensive income
|
$
|
30,525
|
$
|
55,365
|
||||
Add: Income tax provision (benefit)
|
11,649
|
(5,439
|
)
|
|||||
Income before income tax provision (benefit)
|
42,174
|
49,926
|
||||||
Add: Impairment of long lived assets (a)
|
—
|
2,164
|
||||||
Add: Other non-recurring expenses(b)
|
1,346
|
5,081
|
||||||
Add: Accelerated equity-based compensation expense
|
244
|
—
|
||||||
Adjusted Income before provision for income taxes
|
43,764
|
57,171
|
||||||
Less: Adjusted Tax Provision (c)(d)
|
12,079
|
22,868
|
||||||
Adjusted net income
|
$
|
31,685
|
$
|
34,303
|
||||
Adjusted net income per common share attributable to common shareholders
|
||||||||
Basic
|
$
|
0.74
|
$
|
0.82
|
||||
Diluted
|
$
|
0.72
|
$
|
0.79
|
||||
Weighted average number of common shares outstanding
|
||||||||
Basic
|
42,771,316
|
41,926,157
|
||||||
Diluted
|
44,239,751
|
43,571,746
|
(a): |
Represents the impairment of assets taken in fiscal 2017 associated with three underperforming retail locations.
|
(b): |
Represents items management believes are not indicative of ongoing operating performance. These expenses are primarily composed of legal and professional fees associated with the initial public offering completed March 14, 2017 and subsequent transition to a public company. For the fifty-two weeks ended February 2, 2019, these expenses include costs related to a CEO transition.
|
(c): |
The adjusted tax provision for adjusted net income is estimated by applying the effective tax rates of 37.1% and 27.6% for the thirteen and fifty-two weeks ended February 2, 2019, respectively, to the adjusted income before provision for income taxes.
|
(d): |
The adjusted tax provision for adjusted net income is estimated by applying a 40% rate to fiscal 2017 adjusted income before provision for income taxes.
|
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1687932/000095014219000480/eh1900359_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by J.Jill, Inc..
J.Jill, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
J.Jill, Inc. provided additional information to their SEC Filing as exhibits
Ticker: JILLEvents:
CIK: 1687932
Form Type: 8-K Corporate News
Accession Number: 0000950142-19-000480
Submitted to the SEC: Wed Mar 06 2019 6:51:33 AM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Wednesday, March 6, 2019
Industry: Womens Misses And Juniors Outerwear